Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1963 3
1964 4
1965 1
1966 1
1967 1
1968 1
1972 1
1974 1
1975 2
1976 2
1977 5
1978 2
1979 3
1981 1
1982 2
1984 5
1985 3
1986 4
1987 1
1988 2
1989 6
1990 4
1991 1
1992 3
1993 2
1994 1
1996 2
1997 1
1998 3
1999 3
2000 3
2001 4
2002 6
2003 3
2004 2
2005 1
2006 4
2007 3
2008 5
2010 4
2011 3
2012 4
2013 6
2014 7
2015 4
2016 4
2017 7
2018 8
2019 1
2020 2
2021 6
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and Adolescents.
Kloosterboer SM, Egberts KM, de Winter BCM, van Gelder T, Gerlach M, Hillegers MHJ, Dieleman GC, Bahmany S, Reichart CG, van Daalen E, Kouijzer MEJ, Dierckx B, Koch BCP. Kloosterboer SM, et al. Clin Pharmacokinet. 2020 Nov;59(11):1393-1405. doi: 10.1007/s40262-020-00894-y. Clin Pharmacokinet. 2020. PMID: 32394297 Free PMC article.
BACKGROUND: Pipamperone is a frequently prescribed antipsychotic in children and adolescents in the Netherlands, Belgium, and Germany. ...When dosing pipamperone in children and adolescents, bodyweight should be taken into account....
BACKGROUND: Pipamperone is a frequently prescribed antipsychotic in children and adolescents in the Netherlands, Belgium, and Germany …
Pipamperone and delirium: a preliminary evaluation of its effectiveness in the management of delirium and its subtypes.
Boettger S, Knöpfel S, Schubert M, Garcia Nuñez D, Plichta MM, Klaghofer R, Jenewein J. Boettger S, et al. Swiss Med Wkly. 2017 Jul 24;147:w14471. doi: 10.4414/smw.2017.14471. eCollection 2017. Swiss Med Wkly. 2017. PMID: 28750419 Free article.
With pipamperone as an adjunct to haloperidol, delirium resolved in 59% of patients, over a mean of 7.4 (2-20) days. ...Pipamperone proved to be equally effective in all delirium subtypes - hypoactive, hyperactive and mixed. ...
With pipamperone as an adjunct to haloperidol, delirium resolved in 59% of patients, over a mean of 7.4 (2-20) days. ...Pipamperon …
[Overdosing of pipamperone from a squeeze bottle].
de Roo JHC, Bosch TM, van Rhijn A, Del Canho R. de Roo JHC, et al. Ned Tijdschr Geneeskd. 2018;162:D2160. Ned Tijdschr Geneeskd. 2018. PMID: 29543144 Dutch.
He had apparently been given pipamperone in streams rather than in drops in the previous months. The pipamperone level in his blood was raised to toxic levels. The pipamperone drops were delivered in a plastic squeeze bottle (LDPE bottle), which makes correct …
He had apparently been given pipamperone in streams rather than in drops in the previous months. The pipamperone level in his …
Pipamperone (Dipiperon, R3345) in troublesome mental retardates: a double-blind placebo controlled cross-over study with long-term follow-up.
van Hemert JC. van Hemert JC. Acta Psychiatr Scand. 1975 Oct;52(4):237-45. doi: 10.1111/j.1600-0447.1975.tb00039.x. Acta Psychiatr Scand. 1975. PMID: 1103575 Clinical Trial.
After a 2-week washout period, patients were randomly allocated to either pipamperone or placebo treatment. The initial dosage of pipamperone was 40 mg b.i.d., which was gradually increased to 80 mg b.i.d. within 5 days. ...The nursing staff considered the patients …
After a 2-week washout period, patients were randomly allocated to either pipamperone or placebo treatment. The initial dosage of …
[Pipamperone and the treatment of impulsive aggressive behaviour].
Klaassen AA. Klaassen AA. Tijdschr Psychiatr. 2008;50(3):179-83. Tijdschr Psychiatr. 2008. PMID: 18324605 Free article. Dutch.
BACKGROUND: Pipamperone is prescribed to prevent impulsive aggressive behaviour in patients with intermittent explosive disorder, personality disorders or mental retardation. AIM: To investigate the scientific basis of this treatment. METHOD: Various databases were searche …
BACKGROUND: Pipamperone is prescribed to prevent impulsive aggressive behaviour in patients with intermittent explosive disorder, per …
Dose-dependent QTc interval prolongation under haloperidol and pipamperone in the management of delirium in a naturalistic setting.
Bohny P, Boettger S, Jenewein J. Bohny P, et al. Front Psychiatry. 2023 Oct 3;14:1257755. doi: 10.3389/fpsyt.2023.1257755. eCollection 2023. Front Psychiatry. 2023. PMID: 37854439 Free PMC article.
This study aimed to investigate the frequency and magnitude of QTc interval prolongation and clinically relevant side effects occurring in delirium patients managed with haloperidol and/or pipamperone. METHODS: This descriptive retrospective cohort study evaluated 102 elde …
This study aimed to investigate the frequency and magnitude of QTc interval prolongation and clinically relevant side effects occurring in d …
Pharmacokinetics of pipamperone from three different tablet formulations.
Potgieter GE, Groenewoud G, Jordaan PJ, Hundt HK, Schall R, Kummer M, Sewarte-Ross G. Potgieter GE, et al. Arzneimittelforschung. 2002;52(6):430-4. doi: 10.1055/s-0031-1299910. Arzneimittelforschung. 2002. PMID: 12109042 Clinical Trial.
In each treatment phase, subjects received a single dose of 144 mg pipamperone dihydrochloride (CAS 2448-68-2) (equivalent to 120 mg pipamperone; CAS 1893-33-0) as either the reference product (3 x 40 mg tablets), test product A (3 x 40 mg tablets) or test product B …
In each treatment phase, subjects received a single dose of 144 mg pipamperone dihydrochloride (CAS 2448-68-2) (equivalent to 120 mg …
Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report.
Paraschakis A. Paraschakis A. Clin Neuropharmacol. 2014 Mar-Apr;37(2):60-1. doi: 10.1097/WNF.0000000000000021. Clin Neuropharmacol. 2014. PMID: 24614672
We present a case of a 37-year-old patient with refractory schizophrenia who has responded well to the combination of clozapine, sodium valproate, and pipamperone. The improvement was more evident in the following symptoms: auditory hallucinations, delusions, formal though …
We present a case of a 37-year-old patient with refractory schizophrenia who has responded well to the combination of clozapine, sodium valp …
Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor.
Van Craenenbroeck K, Gellynck E, Lintermans B, Leysen JE, Van Tol HH, Haegeman G, Vanhoenacker P. Van Craenenbroeck K, et al. Life Sci. 2006 Dec 3;80(1):74-81. doi: 10.1016/j.lfs.2006.08.024. Epub 2006 Aug 25. Life Sci. 2006. PMID: 16978659
Addition of the dopamine D4 receptor and serotonin 5-HT2A receptor antagonist pipamperone to these cells further increased the expression of the dopamine receptor, reaching 3800 +/- 60 fmol/mg membrane protein. ...We further provide evidence that the increase in receptor e …
Addition of the dopamine D4 receptor and serotonin 5-HT2A receptor antagonist pipamperone to these cells further increased the expres …
155 results